FINCH HARRY,FOX CRAIG,SAJAD MOHAMMED,FINCH Harry,FOX Craig,SAJAD Mohammed
申请号：
SI200930499
公开号：
SI2222272T1
申请日:
2009.08.05
申请国别(地区):
SI
年份:
2013
代理人:
摘要：
There is provided a pharmaceutical composition that is adapted for pulmonary administration by inhalation, which composition comprises a glitazone, such as pioglitazone or rosiglitazone, and one or more pharmaceutically acceptable carriers and/or excipients, and wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. There is also provided a use and a kit.
